Ifp Advisors, Inc Fate Therapeutics Inc Transaction History

Ifp Advisors, Inc

  • $3.28 Billion
  • Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 85 shares of FATE stock, worth $130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Holding current value
$130
% of portfolio
0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025
BUY
$0.68 - $1.67 $57 - $141
85 New
85 $0
Q4 2024

Feb 04, 2025
SELL
$1.61 - $3.35 $5,364 - $11,162
-3,332 Reduced 99.17%
28 $0
Q1 2023

Apr 18, 2023
SELL
$4.24 - $11.12 $2,344 - $6,149
-553 Reduced 14.13%
3,360 $19,000
Q4 2022

Feb 07, 2023
BUY
$9.86 - $23.83 $364 - $881
37 Added 0.95%
3,913 $44,000
Q3 2022

Nov 08, 2022
BUY
$21.04 - $36.06 $715 - $1,226
34 Added 0.88%
3,876 $43,000
Q2 2022

Sep 06, 2022
BUY
$17.78 - $42.39 $68,310 - $162,862
3,842 New
3,842 $43,000
Q2 2022

Aug 12, 2022
SELL
$17.78 - $42.39 $68,310 - $162,862
-3,842 Closed
0 $0
Q1 2022

Sep 06, 2022
BUY
$29.67 - $60.28 $94,261 - $191,509
3,177 Added 477.74%
3,842 $148,000
Q1 2022

Aug 08, 2022
BUY
$29.67 - $60.28 $19,730 - $40,086
665 New
665 $25,000
Q3 2021

Oct 06, 2021
SELL
$59.27 - $95.73 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021
SELL
$67.25 - $92.52 $10,087 - $13,878
-150 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$72.16 - $117.4 $10,824 - $17,610
150 New
150 $12,000
Q4 2020

Jan 25, 2021
BUY
$38.09 - $100.95 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020
BUY
$30.41 - $40.5 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020
BUY
$20.21 - $35.23 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020
BUY
$17.28 - $31.88 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020
SELL
$13.39 - $20.73 $267 - $414
-20 Closed
0 $0
Q3 2019

Nov 07, 2019
BUY
$15.47 - $22.5 $309 - $450
20 New
20 $0
Q1 2019

May 15, 2019
SELL
$13.15 - $18.71 $317,677 - $451,996
-24,158 Closed
0 $0
Q4 2018

Jan 23, 2019
BUY
$11.48 - $16.98 $36,552 - $54,064
3,184 Added 15.18%
24,158 $309,000
Q3 2018

Oct 25, 2018
SELL
$8.75 - $16.29 $30,852 - $57,438
-3,526 Reduced 14.39%
20,974 $0
Q2 2018

Aug 07, 2018
BUY
$9.16 - $13.48 $136,484 - $200,852
14,900 Added 155.21%
24,500 $0
Q1 2018

Jun 03, 2019
SELL
$6.3 - $13.77 $38,902 - $85,029
-6,175 Reduced 39.14%
9,600 $59,000
Q1 2018

May 09, 2018
BUY
$6.3 - $13.77 $38,902 - $85,029
6,175 Added 64.32%
15,775 $0
Q4 2017

Jan 24, 2018
BUY
$3.94 - $6.64 $15,760 - $26,560
4,000 Added 71.43%
9,600 $0
Q3 2017

Oct 30, 2017
BUY
$2.6 - $4.31 $1,300 - $2,155
500 Added 9.8%
5,600 $22,000
Q2 2017

Jun 03, 2019
SELL
N/A
-300 Reduced 5.56%
5,100 $17,000
Q1 2017

Jun 03, 2019
SELL
N/A
-6,640 Reduced 55.15%
5,400 $25,000
Q4 2016

Jun 03, 2019
BUY
N/A
6,840 Added 131.54%
12,040 $30,000
Q2 2016

Jun 03, 2019
BUY
N/A
5,200
5,200 $9,000

Others Institutions Holding FATE

# of Institutions
151
Shares Held
83.5M
Call Options Held
179K
Put Options Held
13.4K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $149M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email